Aberrant activation of FZD7 has been found in several types of cancer such as breast (Yang et al., 2011), colorectal (Ueno et al., 2009), hepatocellular carcinoma (Merle et al., 2005), and gastric cancer (Kirikoshi et al., 2001). Here, FZD7 is linked to cancer.